The North America Joint Pain Injections Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
The two most common varieties of arthritis are rheumatoid arthritis, an inflammatory condition that typically affects the hands and feet, and osteoarthritis, a degenerative joint disease. Growing older, becoming more obese, avoiding exercising, and diminishing bone mineral density are all risk factors for osteoarthritis. Hyaluronic acid and corticosteroid injections are frequently utilized to reduce swelling and discomfort in affected joint locations. Joint pain can be treated, and direct joint injections can reduce edema and inflammation. The majority of the time, pre-existing illnesses or abnormalities in the elderly are what causes joint discomfort. The primary sites of the spine most frequently affected by arthritis are the ankle, elbow, knee, hip, shoulder, and facet joints. The pain it causes in the joints, which then, in turn, causes inflammation, makes joint discomfort worse.
The therapy options that are currently accessible are insufficient because they mainly concentrate on symptom alleviation and pain management. There are now no medications that can treat, stop the progression of, or reverse diseases like osteoarthritis. There are significant unmet requirements in patients with joint pain since some people cannot relieve their pain with treatment options and continue to experience it. This opens the market for joint pain injections to more cutting-edge therapy alternatives.
According to the Centers for Disease Control and Prevention, there are currently 59 million persons with arthritis in the United States, an increase of over 4 million during 2013–2015. The population living with activity restrictions due to arthritis is expected to rise 46% by 2040, making it one of the top causes of disability in the nation (from 23.7 million during 2013–2015 to 34.6 million). Approximately 23% of US people are overweight, and 31% of those who are obese have arthritis that has been medically diagnosed.
A diagnosis of rheumatoid arthritis affects over 374,000 (1.2%) Canadians aged 16 and older, and 23,000 (0.8 per 1,000 people per year) people had a new diagnosis in 2016–2017. Rheumatoid arthritis diagnosis prevalence and incidence are higher in women than men and generally rise with age. The demand for joint pain injections is expected to increase significantly in North America due to the increased prevalence of arthritis in the region.
The US market dominated the North America Joint Pain Injections Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,817.2 Million by 2028. The Canada market is experiencing a CAGR of 9.5% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 8.5% during (2022 - 2028).
Based on Injection Type, the market is segmented into Interleukin Inhibitors, Hyaluronic Acid Injections, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Joint Type Channel, the market is segmented into Knee & Ankle, Shoulder & Elbow, Hip Joint, Facet Joints of the Spine, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Joint Pain Injections Market is Estimated to reach $9.9 Billion by 2028, at a CAGR of 7.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.
Scope of the Study
Market Segments Covered in the Report:
By Injection Type
- Interleukin Inhibitors
- Hyaluronic Acid Injections
- Others
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Joint Type
- Knee & Ankle
- Shoulder & Elbow
- Hip Joint
- Facet Joints of the Spine
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bioventus Inc.
- Pacira BioSciences, Inc.
- AbbVie, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Pfizer, Inc.
- Anika Therapeutics, Inc.
- Zimmer Biomet Holdings, Inc.
- Eli Lilly And Company
- Ferring Holdings SA
- Sanofi S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Joint Pain Injections Market, by Injection Type
1.4.2 North America Joint Pain Injections Market, by Distribution Channel
1.4.3 North America Joint Pain Injections Market, by Joint Type
1.4.4 North America Joint Pain Injections Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Joint Pain Injections Market by Injection Type
3.1 North America Interleukin Inhibitors Market by Country
3.2 North America Hyaluronic Acid Injections Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Joint Pain Injections Market by Distribution Channel
4.1 North America Drug Stores & Retail Pharmacies Market by Country
4.2 North America Hospital Pharmacies Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Joint Pain Injections Market by Joint Type
5.1 North America Knee & Ankle Market by Country
5.2 North America Shoulder & Elbow Market by Country
5.3 North America Hip Joint Market by Country
5.4 North America Facet Joints of the Spine Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Joint Pain Injections Market by Country
6.1 US Joint Pain Injections Market
6.1.1 US Joint Pain Injections Market by Injection Type
6.1.2 US Joint Pain Injections Market by Distribution Channel
6.1.3 US Joint Pain Injections Market by Joint Type
6.2 Canada Joint Pain Injections Market
6.2.1 Canada Joint Pain Injections Market by Injection Type
6.2.2 Canada Joint Pain Injections Market by Distribution Channel
6.2.3 Canada Joint Pain Injections Market by Joint Type
6.3 Mexico Joint Pain Injections Market
6.3.1 Mexico Joint Pain Injections Market by Injection Type
6.3.2 Mexico Joint Pain Injections Market by Distribution Channel
6.3.3 Mexico Joint Pain Injections Market by Joint Type
6.4 Rest of North America Joint Pain Injections Market
6.4.1 Rest of North America Joint Pain Injections Market by Injection Type
6.4.2 Rest of North America Joint Pain Injections Market by Distribution Channel
6.4.3 Rest of North America Joint Pain Injections Market by Joint Type
Chapter 7. Company Profiles
7.1 Bioventus Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.2 Pacira BioSciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Research & Development Expenses
7.2.4 Recent strategies and developments:
7.2.4.1 Acquisition and Mergers:
7.3 AbbVie, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Trails and Approvals:
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.6 Anika Therapeutics, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Zimmer Biomet Holdings, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Eli Lilly And Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Ferring Holdings SA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research and Development Expense
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
TABLE 1 North America Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 2 North America Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 3 North America Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 4 North America Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 5 North America Interleukin Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Interleukin Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Hyaluronic Acid Injections Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Hyaluronic Acid Injections Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 North America Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 20 North America Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 21 North America Knee & Ankle Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Knee & Ankle Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Shoulder & Elbow Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Shoulder & Elbow Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Hip Joint Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Hip Joint Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Facet Joints of the Spine Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Facet Joints of the Spine Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Joint Pain Injections Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Joint Pain Injections Market by Country, 2022 - 2028, USD Million
TABLE 33 US Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 34 US Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 35 US Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 36 US Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 37 US Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 US Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 US Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 40 US Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 41 Canada Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 42 Canada Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 43 Canada Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 44 Canada Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 45 Canada Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 Canada Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 Canada Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 48 Canada Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 49 Mexico Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 50 Mexico Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 51 Mexico Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 52 Mexico Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 53 Mexico Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 Mexico Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 Mexico Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 56 Mexico Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 57 Rest of North America Joint Pain Injections Market, 2018 - 2021, USD Million
TABLE 58 Rest of North America Joint Pain Injections Market, 2022 - 2028, USD Million
TABLE 59 Rest of North America Joint Pain Injections Market by Injection Type, 2018 - 2021, USD Million
TABLE 60 Rest of North America Joint Pain Injections Market by Injection Type, 2022 - 2028, USD Million
TABLE 61 Rest of North America Joint Pain Injections Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 62 Rest of North America Joint Pain Injections Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 63 Rest of North America Joint Pain Injections Market by Joint Type, 2018 - 2021, USD Million
TABLE 64 Rest of North America Joint Pain Injections Market by Joint Type, 2022 - 2028, USD Million
TABLE 65 Key Information – Bioventus Inc.
TABLE 66 Key Information – Pacira BioSciences, Inc.
TABLE 67 Key information – AbbVie, Inc.
TABLE 68 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 69 Key Information – Pfizer, Inc.
TABLE 70 Key Information – Anika Therapeutics, Inc.
TABLE 71 key Information – Zimmer Biomet Holdings, Inc.
TABLE 72 Key Information – Eli Lilly And Company
TABLE 73 key information – Ferring Holdings SA
TABLE 74 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research